Pfizer’s Celebrex Faces Legal Challenge
- Share via
From Bloomberg News
Pfizer Inc. may have to defend a patent for its Celebrex painkiller after a challenge by a generic-medicine maker.
An unidentified company is challenging a patent on versions of Celebrex through a Food and Drug Administration application, the agency said.
Celebrex, the world’s top-selling arthritis drug, had sales of $701 million in the third quarter.
Shares of New York-based Pfizer rose 95 cents to $36.50 on the NYSE.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
